DK1817342T3 - Process for affinity purification - Google Patents
Process for affinity purificationInfo
- Publication number
- DK1817342T3 DK1817342T3 DK05817207.3T DK05817207T DK1817342T3 DK 1817342 T3 DK1817342 T3 DK 1817342T3 DK 05817207 T DK05817207 T DK 05817207T DK 1817342 T3 DK1817342 T3 DK 1817342T3
- Authority
- DK
- Denmark
- Prior art keywords
- affinity purification
- affinity
- purification
- Prior art date
Links
- 238000001261 affinity purification Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04078282 | 2004-12-02 | ||
| PCT/NL2005/000829 WO2006059904A1 (en) | 2004-12-02 | 2005-12-02 | Method for affinity purification |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1817342T3 true DK1817342T3 (en) | 2013-06-03 |
Family
ID=34928702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05817207.3T DK1817342T3 (en) | 2004-12-02 | 2005-12-02 | Process for affinity purification |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US20080249285A1 (en) |
| EP (1) | EP1817342B1 (en) |
| JP (2) | JP5875745B2 (en) |
| CN (1) | CN101072794B (en) |
| CA (1) | CA2589839C (en) |
| DK (1) | DK1817342T3 (en) |
| ES (1) | ES2408256T3 (en) |
| PT (1) | PT1817342E (en) |
| WO (1) | WO2006059904A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010533004A (en) * | 2007-07-13 | 2010-10-21 | バク アイピー ベスローテン フェンノートシャップ | Single domain antigen binding protein that binds to mammalian IgG |
| HRP20170069T1 (en) * | 2007-11-12 | 2017-03-24 | Chreto Aps | Dual affinity polypeptides for purification |
| EP2670779B1 (en) | 2011-02-01 | 2017-08-02 | Bac Ip B.V. | Antigen-binding protein directed against epitope in the ch1 domain of human igg antibodies |
| WO2013125221A1 (en) * | 2012-02-21 | 2013-08-29 | 静岡県 | Affinity ligand for antibody purification |
| CN103113455B (en) * | 2012-11-23 | 2015-07-22 | 南宁市蓝光生物技术有限公司 | Preparation and application of hemagglutinin peptide mark recombinant protein immunoaffinity purification enriching column |
| WO2016191659A1 (en) * | 2015-05-28 | 2016-12-01 | Bio-Rad Laboratories, Inc. | Affinity ligands and methods relating thereto |
| US11136609B2 (en) * | 2015-11-09 | 2021-10-05 | National University Corporation Kyoto Institute Of Technology | Separating agent for human serum-derived IgG polyclonal antibodies, and method for separating human serum-derived IgG polyclonal antibodies using same |
| JP6549061B2 (en) | 2016-05-09 | 2019-07-24 | 富士フイルム株式会社 | Image taking apparatus and method, and image taking apparatus control program |
| DE102018110252A1 (en) | 2018-04-27 | 2019-10-31 | Infineon Technologies Ag | Transceiver, system with transceivers and signal |
| CN111423509B (en) * | 2019-01-10 | 2021-07-09 | 瑞阳(苏州)生物科技有限公司 | Affinity chromatography purification method of anti-HSA single domain antibody and fusion protein thereof |
| CN109628436B (en) * | 2019-01-18 | 2022-03-29 | 重庆派金生物科技有限公司 | Preparation method of fixed recombinant human arginase |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0345466A3 (en) * | 1988-05-10 | 1991-04-17 | EASTMAN KODAK COMPANY (a New Jersey corporation) | Generation of chimeric antibodies in vivo by site-specific recombination |
| US6476198B1 (en) * | 1993-07-13 | 2002-11-05 | The Scripps Research Institute | Multispecific and multivalent antigen-binding polypeptide molecules |
| EP0948353A1 (en) * | 1996-10-11 | 1999-10-13 | Bristol-Myers Squibb Company | Methods and compositions for immunomodulation |
| US6670453B2 (en) * | 1997-10-27 | 2003-12-30 | Unilever Patent Holdings B.V. | Multivalent antigen-binding proteins |
| WO1999037681A2 (en) * | 1998-01-26 | 1999-07-29 | Unilever Plc | Method for producing antibody fragments |
| ATE535154T1 (en) * | 1998-03-12 | 2011-12-15 | Vhsquared Ltd | PRODUCTS THAT CONTAIN INACTIVATED YEAST OR MOLD THAT HAVE ACTIVE ANTIBODIES ON THEIR EXTERNAL SURFACE |
| WO2001044301A1 (en) | 1999-11-29 | 2001-06-21 | Unilever Plc | Immobilized single domain antigen-binding molecules |
| EP2284192A3 (en) * | 2002-11-08 | 2011-07-20 | Ablynx N.V. | Camelidae antibodies for sublingual administration |
| EP2267027A3 (en) * | 2002-11-08 | 2011-07-20 | Ablynx N.V. | Method of administering therapeutic polypeptides, and polypeptides therefor |
| JP2010533004A (en) * | 2007-07-13 | 2010-10-21 | バク アイピー ベスローテン フェンノートシャップ | Single domain antigen binding protein that binds to mammalian IgG |
-
2005
- 2005-12-02 US US11/792,145 patent/US20080249285A1/en not_active Abandoned
- 2005-12-02 CN CN2005800415117A patent/CN101072794B/en active Active
- 2005-12-02 DK DK05817207.3T patent/DK1817342T3/en active
- 2005-12-02 ES ES05817207T patent/ES2408256T3/en active Active
- 2005-12-02 WO PCT/NL2005/000829 patent/WO2006059904A1/en active Application Filing
- 2005-12-02 JP JP2007544292A patent/JP5875745B2/en active Active
- 2005-12-02 EP EP05817207A patent/EP1817342B1/en active Active
- 2005-12-02 CA CA2589839A patent/CA2589839C/en active Active
- 2005-12-02 PT PT58172073T patent/PT1817342E/en unknown
-
2013
- 2013-12-06 JP JP2013253665A patent/JP6009431B2/en active Active
-
2015
- 2015-08-06 US US14/820,446 patent/US20160024148A1/en not_active Abandoned
-
2017
- 2017-06-07 US US15/616,781 patent/US20170369527A1/en not_active Abandoned
-
2021
- 2021-04-23 US US17/239,195 patent/US20210347816A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2589839C (en) | 2016-04-05 |
| EP1817342A1 (en) | 2007-08-15 |
| JP6009431B2 (en) | 2016-10-19 |
| JP2014077001A (en) | 2014-05-01 |
| US20080249285A1 (en) | 2008-10-09 |
| JP2008521890A (en) | 2008-06-26 |
| WO2006059904A1 (en) | 2006-06-08 |
| PT1817342E (en) | 2013-05-15 |
| CN101072794A (en) | 2007-11-14 |
| ES2408256T3 (en) | 2013-06-19 |
| CA2589839A1 (en) | 2006-06-08 |
| CN101072794B (en) | 2012-07-04 |
| EP1817342B1 (en) | 2013-03-06 |
| JP5875745B2 (en) | 2016-03-02 |
| US20210347816A1 (en) | 2021-11-11 |
| US20170369527A1 (en) | 2017-12-28 |
| US20160024148A1 (en) | 2016-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL187642A0 (en) | METHODS FOR PURIFYING PROTEINS HAVING Fc REGIONS | |
| DE112006001685A5 (en) | separation processes | |
| DK1879623T3 (en) | GENTERAPY FOR BACKGROUND DISEASES | |
| DK1869065T3 (en) | Process for weak partition chromatography | |
| DE602005021424D1 (en) | welding processes | |
| FI20055581L (en) | Separation method | |
| DE502005010728D1 (en) | RERUNDEPENDENT STEERING REMOVAL | |
| EP1952908A4 (en) | FORM PROCESS | |
| ATE442898T1 (en) | FILTRATION PROCESS | |
| DE602005014583D1 (en) | Bicycle control apparatus | |
| FI20040098L (en) | Gas chromatograph | |
| BRPI0615165A2 (en) | infertility treatment method | |
| DE602005006185D1 (en) | development process | |
| DE602006012689D1 (en) | REVIEW PROCESS | |
| EP1869230A4 (en) | Method for purifying proteins | |
| DK1989189T3 (en) | Adsorbents for protein purification | |
| ITMI20042238A1 (en) | COMPOUNDS FOR FLUOROPOLIRTEREI | |
| DK1817342T3 (en) | Process for affinity purification | |
| FI20041702A0 (en) | Service buffering for process control | |
| DK1955066T3 (en) | CONE-ASSAY METHOD | |
| DE502004011729D1 (en) | Parking assistant for parallel parking | |
| DE502005003987D1 (en) | PROCESS CONTROL SYSTEM | |
| DE602005010809D1 (en) | steering apparatus | |
| GB0503942D0 (en) | Purification process | |
| DE602005003884D1 (en) | steering system |